{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T18:40:03Z","timestamp":1749494403265,"version":"3.41.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s00520-025-09499-2","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T06:48:59Z","timestamp":1746514139000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of chemotherapy and different chemotherapeutic regimens on electrocardiographic parameters in breast cancer women: a retrospective and within-subject longitudinal study"],"prefix":"10.1007","volume":"33","author":[{"given":"Rui-ling","family":"She","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-yu","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen-yu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-yuan","family":"Mu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-han","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-yu","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-yu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhao-xing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiu-quan","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bai-qing","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai-nan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling-quan","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,6]]},"reference":[{"issue":"1","key":"9499_CR1","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1186\/s12885-021-08716-5","volume":"21","author":"M Jakobsen","year":"2021","unstructured":"Jakobsen M, Kolodziejczyk C, Jensen MS et al (2021) Cardiovascular disease in women with breast cancer - a nationwide cohort study. BMC Cancer 21(1):1040","journal-title":"BMC Cancer"},{"issue":"1","key":"9499_CR2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s40659-017-0140-9","volume":"50","author":"M Akram","year":"2017","unstructured":"Akram M, Iqbal M, Daniyal M, Khan AU (2017) Awareness and current knowledge of breast cancer. Biol Res 50(1):33. https:\/\/doi.org\/10.1186\/s40659-017-0140-9","journal-title":"Biol Res"},{"issue":"5","key":"9499_CR3","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3322\/caac.21731","volume":"72","author":"KD Miller","year":"2022","unstructured":"Miller KD, Nogueira L, Devasia T et al (2022) Cancer treatment and survivorship statistics, 2022. CA Cancer J Clin 72(5):409\u2013436","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"9499_CR4","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s10549-017-4282-9","volume":"164","author":"SAM Gernaat","year":"2017","unstructured":"Gernaat SAM, Ho PJ, Rijnberg N et al (2017) Risk of death from cardiovascular disease following breast cancer: a systematic review. Breast Cancer Res Treat 164(3):537\u2013555","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"9499_CR5","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1093\/eurheartj\/ehab745","volume":"43","author":"A Guha","year":"2022","unstructured":"Guha A, Fradley MG, Dent SF et al (2022) Incidence, risk factors, and mortality of atrial fibrillation in breast cancer: a SEER-Medicare analysis. Eur Heart J 43(4):300\u2013312","journal-title":"Eur Heart J"},{"issue":"8","key":"9499_CR6","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1093\/jnci\/djy218","volume":"111","author":"H Abdel-Qadir","year":"2019","unstructured":"Abdel-Qadir H, Thavendiranathan P, Austin PC et al (2019) The risk of heart failure and other cardiovascular hospitalizations after early stage breast cancer: a matched cohort study. J Natl Cancer Inst 111(8):854\u2013862","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"9499_CR7","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1634\/theoncologist.2016-0406","volume":"22","author":"AF Yu","year":"2017","unstructured":"Yu AF, Singh JC, Wang R et al (2017) Cardiac safety of dual anti-HER2 therapy in the neoadjuvant setting for treatment of HER2-positive breast cancer. Oncologist 22(6):642\u2013647","journal-title":"Oncologist"},{"issue":"1","key":"9499_CR8","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.tcm.2019.01.006","volume":"30","author":"A Padegimas","year":"2020","unstructured":"Padegimas A, Clasen S, Ky B (2020) Cardioprotective strategies to prevent breast cancer therapy-induced cardiotoxicity. Trends Cardiovasc Med 30(1):22\u201328","journal-title":"Trends Cardiovasc Med"},{"issue":"10","key":"9499_CR9","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1016\/j.amjmed.2021.05.026","volume":"134","author":"H Essa","year":"2021","unstructured":"Essa H, Wright DJ, Dobson R, Lip GYH (2021) Chemotherapy-induced arrhythmia - underrecognized and undertreated. Am J Med 134(10):1224\u20131231.e1","journal-title":"Am J Med"},{"issue":"8","key":"9499_CR10","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1161\/CIRCULATIONAHA.118.039371","volume":"139","author":"R Barish","year":"2019","unstructured":"Barish R, Lynce F, Unger K, Barac A (2019) Management of cardiovascular disease in women with breast cancer. Circulation 139(8):1110\u20131120","journal-title":"Circulation"},{"issue":"2","key":"9499_CR11","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1124\/pr.56.2.6","volume":"56","author":"G Minotti","year":"2004","unstructured":"Minotti G, Menna P, Salvatorelli E, Cairo G, Gianni L (2004) Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev 56(2):185\u2013229","journal-title":"Pharmacol Rev"},{"issue":"11","key":"9499_CR12","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/nrclinonc.2009.146","volume":"6","author":"A Emadi","year":"2009","unstructured":"Emadi A, Jones RJ, Brodsky RA (2009) Cyclophosphamide and cancer: golden anniversary. Nat Rev Clin Oncol 6(11):638\u2013647","journal-title":"Nat Rev Clin Oncol"},{"issue":"9","key":"9499_CR13","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.chembiol.2017.08.028","volume":"24","author":"A Luengo","year":"2017","unstructured":"Luengo A, Gui DY, Vander Heiden MG (2017) Targeting metabolism for cancer therapy. Cell Chem Biol 24(9):1161\u20131180","journal-title":"Cell Chem Biol"},{"issue":"24","key":"9499_CR14","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s11658-019-0164-y","volume":"13","author":"L Zhu","year":"2019","unstructured":"Zhu L, Chen L (2019) Progress in research on paclitaxel and tumor immunotherapy. Cell Mol Biol Lett 13(24):40","journal-title":"Cell Mol Biol Lett"},{"issue":"2","key":"9499_CR15","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/jnci\/djaa096","volume":"113","author":"C Ramin","year":"2021","unstructured":"Ramin C, Schaeffer ML, Zheng Z et al (2021) All-cause and cardiovascular disease mortality among breast cancer survivors in CLUE II, a long-standing community-based cohort. J Natl Cancer Inst 113(2):137\u2013145","journal-title":"J Natl Cancer Inst"},{"issue":"48","key":"9499_CR16","doi-asserted-by":"publisher","first-page":"3898","DOI":"10.1093\/eurheartj\/ehz781","volume":"40","author":"J Herrmann","year":"2019","unstructured":"Herrmann J (2019) From trends to transformation: where cardio-oncology is to make a difference. Eur Heart J 40(48):3898\u20133900","journal-title":"Eur Heart J"},{"issue":"3","key":"9499_CR17","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11886-021-01446-x","volume":"23","author":"DH Chen","year":"2021","unstructured":"Chen DH, Tyebally S, Malloupas M et al (2021) Cardiovascular disease amongst women treated for breast cancer: traditional cytotoxic chemotherapy, Targeted Therapy, and Radiation Therapy. Curr Cardiol Rep 23(3):16","journal-title":"Curr Cardiol Rep"},{"key":"9499_CR18","unstructured":"Mehta LS, Watson KE, Barac A et al (2018) American heart association cardiovascular disease in women and special populations committee of the council on clinical cardiology; council on cardiovascular and stroke nursing; and council on quality of care and outcomes research. Cardiovascular disease and breast cancer: where these entities intersect: a scientific statement from the american heart association. Circulation 137(8):e30-e66"},{"issue":"2","key":"9499_CR19","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/jnci\/djaa097","volume":"113","author":"AH Blaes","year":"2021","unstructured":"Blaes AH, Konety SH (2021) Cardiovascular disease in breast cancer survivors: an important topic in breast cancer survivorship. J Natl Cancer Inst 113(2):105\u2013106","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"9499_CR20","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.007724","volume":"6","author":"A Porta-S\u00e1nchez","year":"2017","unstructured":"Porta-S\u00e1nchez A, Gilbert C, Spears D et al (2017) Incidence, diagnosis, and management of QT prolongation induced by cancer therapies: a systematic review. J Am Heart Assoc 6(12):e007724","journal-title":"J Am Heart Assoc"},{"issue":"1096","key":"9499_CR21","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1136\/postgradmedj-2016-134417","volume":"93","author":"TM Okwuosa","year":"2017","unstructured":"Okwuosa TM, Anzevino S, Rao R (2017) Cardiovascular disease in cancer survivors. Postgrad Med J 93(1096):82\u201390","journal-title":"Postgrad Med J"},{"issue":"15","key":"9499_CR22","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1200\/JCO.21.01736","volume":"40","author":"H Greenlee","year":"2022","unstructured":"Greenlee H, Iribarren C, Rana JS et al (2022) Risk of cardiovascular disease in women with and without breast cancer: the pathways heart study. J Clin Oncol 40(15):1647\u20131658","journal-title":"J Clin Oncol"},{"issue":"5","key":"9499_CR23","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1001\/jamaoncol.2019.0038","volume":"5","author":"K Lee","year":"2019","unstructured":"Lee K, Tripathy D, Demark-Wahnefried W et al (2019) Effect of aerobic and resistance exercise intervention on cardiovascular disease risk in women with early-stage breast cancer: a randomized clinical trial. JAMA Oncol 5(5):710\u2013714","journal-title":"JAMA Oncol"},{"issue":"48","key":"9499_CR24","doi-asserted-by":"publisher","first-page":"3889","DOI":"10.1093\/eurheartj\/ehz766","volume":"40","author":"KM Sturgeon","year":"2019","unstructured":"Sturgeon KM, Deng L, Bluethmann SM et al (2019) A population-based study of cardiovascular disease mortality risk in US cancer patients. Eur Heart J 40(48):3889\u20133897","journal-title":"Eur Heart J"},{"issue":"3","key":"9499_CR25","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/nrclinonc.2015.171","volume":"13","author":"TM Zagar","year":"2016","unstructured":"Zagar TM, Cardinale DM, Marks LB (2016) Breast cancer therapy-associated cardiovascular disease. Nat Rev Clin Oncol 13(3):172\u2013184","journal-title":"Nat Rev Clin Oncol"},{"issue":"6","key":"9499_CR26","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1001\/jamaoncol.2020.7468","volume":"7","author":"I Meattini","year":"2021","unstructured":"Meattini I, Poortmans PM, Aznar MC et al (2021) Association of breast cancer irradiation with cardiac toxic effects: a narrative review. JAMA Oncol 7(6):924\u2013932","journal-title":"JAMA Oncol"},{"key":"9499_CR27","doi-asserted-by":"crossref","unstructured":"Kirkham AA, Beaudry RI, Paterson DI, Mackey JR, Haykowsky MJ (2019) Curing breast cancer and killing the heart: a novel model to explain elevated cardiovascular disease and mortality risk among women with early stage breast cancer. Prog Cardiovasc Dis 62(2):116\u2013126","DOI":"10.1016\/j.pcad.2019.02.002"},{"issue":"7","key":"9499_CR28","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s40264-016-0411-3","volume":"39","author":"M Malik","year":"2016","unstructured":"Malik M (2016) Drug-induced QT\/QTc interval shortening: lessons from drug-induced QT\/QTc prolongation. Drug Saf 39(7):647\u2013659","journal-title":"Drug Saf"},{"issue":"1","key":"9499_CR29","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/ejhf.2079","volume":"23","author":"D Farmakis","year":"2021","unstructured":"Farmakis D, Filippatos G (2021) Arrhythmias in cancer: rhythm is gonna get you! Eur J Heart Fail 23(1):154\u2013156","journal-title":"Eur J Heart Fail"},{"issue":"10","key":"9499_CR30","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.biopha.2004.12.003","volume":"59","author":"F Galetta","year":"2005","unstructured":"Galetta F, Franzoni F, Cervetti G et al (2005) Effect of epirubicin-based chemotherapy and dexrazoxane supplementation on QT dispersion in non-Hodgkin lymphoma patients. Biomed Pharmacother 59(10):541\u2013544","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"9499_CR31","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1039\/D1NP00059D","volume":"39","author":"MB Hulst","year":"2022","unstructured":"Hulst MB, Grocholski T, Neefjes JJC, van Wezel GP, Mets\u00e4-Ketel\u00e4 M (2022) Anthracyclines: biosynthesis, engineering and clinical applications. Nat Prod Rep 39(4):814\u2013841","journal-title":"Nat Prod Rep"},{"key":"9499_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.104542","volume":"151","author":"J Benjanuwattra","year":"2020","unstructured":"Benjanuwattra J, Siri-Angkul N, Chattipakorn SC, Chattipakorn N (2020) doxorubicin and its proarrhythmic effects: a comprehensive review of the evidence from experimental and clinical studies. Pharmacol Res 151:104542","journal-title":"Pharmacol Res"},{"issue":"866","key":"9499_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2019.172818","volume":"5","author":"N Prathumsap","year":"2020","unstructured":"Prathumsap N, Shinlapawittayatorn K, Chattipakorn SC, Chattipakorn N (2020) Effects of doxorubicin on the heart: from molecular mechanisms to intervention strategies. Eur J Pharmacol 5(866):172818","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"9499_CR34","doi-asserted-by":"publisher","first-page":"12759","DOI":"10.1038\/s41598-023-40061-4","volume":"13","author":"N Osataphan","year":"2023","unstructured":"Osataphan N, Phrommintikul A, Leemasawat K et al (2023) Effects of metformin and donepezil on the prevention of doxorubicin-induced cardiotoxicity in breast cancer: a randomized controlled trial. Sci Rep 13(1):12759","journal-title":"Sci Rep"},{"issue":"7","key":"9499_CR35","doi-asserted-by":"publisher","first-page":"44877","DOI":"10.1038\/srep44877","volume":"20","author":"H Han","year":"2017","unstructured":"Han H, Guo W, Shi W et al (2017) Hypertension and breast cancer risk: a systematic review and meta-analysis. Sci Rep 20(7):44877","journal-title":"Sci Rep"},{"key":"9499_CR36","doi-asserted-by":"crossref","unstructured":"Gongora CA, Drobni ZD, Quinaglia Araujo Costa Silva T et al (2022) Sodium-glucose co-transporter-2 inhibitors and cardiac outcomes among patients treated with anthracyclines. JACC Heart Fail 10(8):559\u2013567","DOI":"10.1016\/j.jchf.2022.03.006"},{"issue":"8","key":"9499_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003731","volume":"18","author":"GQ Zhang","year":"2021","unstructured":"Zhang GQ, Chen JL, Luo Y et al (2021) Menopausal hormone therapy and women\u2019s health: an umbrella review. PLoS Med 18(8):e1003731","journal-title":"PLoS Med"},{"issue":"5","key":"9499_CR38","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1001\/jama.2022.24140","volume":"329","author":"CJ Crandall","year":"2023","unstructured":"Crandall CJ, Mehta JM, Manson JE (2023) Management of menopausal symptoms: a review. JAMA 329(5):405\u2013420","journal-title":"JAMA"},{"issue":"4","key":"9499_CR39","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/nrendo.2017.180","volume":"14","author":"P Monteleone","year":"2018","unstructured":"Monteleone P, Mascagni G, Giannini A, Genazzani AR, Simoncini T (2018) Symptoms of menopause - global prevalence, physiology and implications. Nat Rev Endocrinol 14(4):199\u2013215","journal-title":"Nat Rev Endocrinol"},{"issue":"13","key":"9499_CR40","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1136\/heartjnl-2017-312251","volume":"104","author":"M Seviiri","year":"2018","unstructured":"Seviiri M, Lynch BM, Hodge AM et al (2018) Resting heart rate, temporal changes in resting heart rate, and overall and cause-specific mortality. Heart 104(13):1076\u20131085","journal-title":"Heart"},{"issue":"10","key":"9499_CR41","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1634\/theoncologist.2017-0672","volume":"23","author":"AN Shah","year":"2018","unstructured":"Shah AN, Gradishar WJ (2018) Adjuvant anthracyclines in breast cancer: what is their role? Oncologist 23(10):1153\u20131161","journal-title":"Oncologist"},{"issue":"5","key":"9499_CR42","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1093\/cvr\/cvz023","volume":"115","author":"I Raber","year":"2019","unstructured":"Raber I, Asnani A (2019) Cardioprotection in cancer therapy: novel insights with anthracyclines. Cardiovasc Res 115(5):915\u2013921","journal-title":"Cardiovasc Res"},{"issue":"1","key":"9499_CR43","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.tips.2022.10.003","volume":"44","author":"L Wu","year":"2023","unstructured":"Wu L, Wang L, Du Y, Zhang Y, Ren J (2023) Mitochondrial quality control mechanisms as therapeutic targets in doxorubicin-induced cardiotoxicity. Trends Pharmacol Sci 44(1):34\u201349","journal-title":"Trends Pharmacol Sci"},{"issue":"12","key":"9499_CR44","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/S2352-4642(22)00239-5","volume":"6","author":"EC Baat","year":"2022","unstructured":"Baat EC, van Dalen EC, Mulder RL et al (2022) Primary cardioprotection with dexrazoxane in patients with childhood cancer who are expected to receive anthracyclines: recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Child Adolesc Health 6(12):885\u2013894","journal-title":"Lancet Child Adolesc Health"},{"issue":"4","key":"9499_CR45","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/j.ymthe.2020.12.035","volume":"29","author":"S Chatterjee","year":"2021","unstructured":"Chatterjee S, Hofer T, Costa A et al (2021) Telomerase therapy attenuates cardiotoxic effects of doxorubicin. Mol Ther 29(4):1395\u20131410","journal-title":"Mol Ther"},{"issue":"14","key":"9499_CR46","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1056\/NEJMoa0910383","volume":"365","author":"D Slamon","year":"2011","unstructured":"Slamon D, Eiermann W, Robert N et al (2011) Adjuvant trastuzumab in HER2-positive breast cancer. N Engl J Med 365(14):1273\u20131283","journal-title":"N Engl J Med"},{"issue":"2","key":"9499_CR47","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jaccao.2019.09.007","volume":"1","author":"JAM Kamphuis","year":"2019","unstructured":"Kamphuis JAM, Linschoten M, Cramer MJ et al (2019) Cancer therapy-related cardiac dysfunction of nonanthracycline chemotherapeutics: what is the evidence? JACC CardioOncol 1(2):280\u2013290","journal-title":"JACC CardioOncol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09499-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-025-09499-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09499-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T18:03:26Z","timestamp":1749492206000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-025-09499-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,6]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["9499"],"URL":"https:\/\/doi.org\/10.1007\/s00520-025-09499-2","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"type":"print","value":"0941-4355"},{"type":"electronic","value":"1433-7339"}],"subject":[],"published":{"date-parts":[[2025,5,6]]},"assertion":[{"value":"19 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of the First Affiliated Hospital of Chongqing Medical University, and the review batch number is 2022-K449.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"452"}}